Vanderbilt-Ingram Cancer Center - Cool Springs — Nashville, Tennessee

Public research footprint of Vanderbilt-Ingram Cancer Center - Cool Springs, compiled from the ClinicalTrials.gov public registry.

131

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Recurrent Ovarian Carcinoma · Invasive Breast Carcinoma · Stage IIIA Lung Non-Small Cell Cancer AJCC v7

Recently updated registry entries

NCT02224781 — Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and… (Active Not Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)
NCT02003222 — Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Vanderbilt-Ingram Cancer Center - Cool Springs?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.